BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9061265)

  • 1. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated mammographic screening reduces breast cancer mortality along the continuum of age.
    Broeders MJ; Verbeek AL; Straatman H; Peer PG; Jong PC; Beex LV; Hendriks JH; Holland R
    J Med Screen; 2002; 9(4):163-7. PubMed ID: 12518006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
    Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
    Int J Cancer; 1996 Jun; 66(6):727-31. PubMed ID: 8647640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to mammography failure in women aged 40-49 years.
    Buist DS; Porter PL; Lehman C; Taplin SH; White E
    J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project.
    Brisson J; Morrison AS; Khalid N
    J Natl Cancer Inst; 1988 Dec; 80(19):1534-40. PubMed ID: 3255294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.
    van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M
    J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening.
    Kricker A; Farac K; Smith D; Sweeny A; McCredie M; Armstrong BK
    Int J Cancer; 1999 Jun; 81(6):877-80. PubMed ID: 10362133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic screening for women aged 40 to 49 years: the primary care practitioner's dilemma.
    Sickles EA; Kopans DB
    Ann Intern Med; 1995 Apr; 122(7):534-8. PubMed ID: 7872590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer screening in the elderly].
    Amodeo C; Caglià P; Gandolfo L; Veroux M; Brancato G; Immè A
    Tumori; 2003; 89(4 Suppl):173-4. PubMed ID: 12903582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
    Chang HR; Cole B; Bland KI
    J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.